AUG 17, 2019 08:44 AM PDT

New method to stop metastasis in lymph nodes

Research reported recently in ACS Nano explains a new method of targeting metastases in lymph nodes as a means of preventing the spread of cancers. The approach could provide novel treatment methods for patients vulnerable to metastasis, the process during which cancer cells separate from the primary tumor to form tumors at other sites. Metastasis is leading cause of cancer deaths.

This strategy targets lymph nodes because metastatic cancer usually spreads first to these glands through small vessels called lymphatics, which carry immune cells and fluid. While most conventional treatment options utilize biopsies of the lymph nodes to see if metastasis has occurred, taking a biopsy is an invasive procedure that can cause pain and infection. Instead of biopsies, the method developed by researchers Hong-Jun Li, Jin-Zhi Du and colleagues uses a nanoparticle delivery tool, called iCluster.

iCluster is already used as a nanoparticle delivery tool to bring chemotherapies directly to tumors, but by injecting iCluster combined with a red dye into mice with tumors, the researchers figured out that iCluster is also capable of entering a tumor and passing through the lymphatics. Using fluorescent imaging, the scientists saw that this mechanism provides a channel to target the lymph nodes directly and potentially treat metastases.

The study concluded that 40% of the treated mice treated with iCluster were still alive 110 days following the removal of the tumor; in comparison, those mice that did not receive treatment from iCluster before the removal of tumors all died from metastases within 51 days of surgery. Additionally, while the iCluster-treated mice lived longer, they also were seen to have far fewer tumors than untreated mice.

The authors explain their findings, stating, “Here, we uncovered that improved perfusion in a primary tumor facilitates nanoparticle translocation to lymph nodes for inhibiting tumor metastasis. On the basis of our finding that an iCluster platform…markedly improved particle perfusion in the interstitium of the primary tumor, we further revealed in the current study that such tumor-specific size transition promoted particle intravasation into tumor lymphatics and migration into lymph nodes.”

Sources: Science Daily, ACS Nano

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
SEP 16, 2019
Cancer
SEP 16, 2019
Could eating yogurt reduce your risk of cancer?
Better go stock up on yogurt – at least according to a new study published in the BMJ journal Gut from the Harvard T.H. Chan School of Public Health....
SEP 16, 2019
Cancer
SEP 16, 2019
An Ointment to Stop Skin Cancer Growth
Russian scientists are developing an ointment to undermine the growth of skin cancer, according to a review recently published in Molecules. One in three c...
SEP 16, 2019
Cancer
SEP 16, 2019
Combining Breast and Lung Cancer Drugs to Overcome Treatment Resistance
The efforts to overcome cancer’s ability to evolve and resist treatment take many forms and comprise a vital and active branch of contemporary cancer...
SEP 16, 2019
Cancer
SEP 16, 2019
Understanding osteosarcoma in kids and dogs
New research published in the Nature journal, Communications Biology, shows evidence for a comparative study that scientists could use to improve treatment...
SEP 16, 2019
Cancer
SEP 16, 2019
Could electromagnetic fields treat metastatic triple-negative breast cancer?
New research published in Communications Biology suggests that electromagnetic fields are capable of stopping the metastasis of some breast cancer cells. I...
SEP 16, 2019
Cancer
SEP 16, 2019
Eat more flavonoids!
An apple a day keeps the doctor away? New research published in Nature Communications suggests that there might be some truth to that old saying. But it&rs...
Loading Comments...